Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

March 24, 2021

Study Completion Date

March 24, 2021

Conditions
BioequivalenceHealthy Subjects
Interventions
DRUG

Exib 120 mg etoricoxib film-coated tablets

Oral, COX-2 highly selective, non-steroidal anti-inflammatory generic drug

DRUG

Arcoxia® 120 mg etoricoxib film-coated tablets

Oral, COX-2 highly selective, non-steroidal anti-inflammatory innovative drug

Trial Locations (1)

38038

Erciyes University Hakan Çetinsaya İyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), Kayseri

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Anapharm

INDUSTRY

lead

Darnitsa Pharmaceutical Company

INDUSTRY

NCT05014490 - Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers | Biotech Hunter | Biotech Hunter